The report identifies key opportunities in Antibody-Drug Conjugates through insights on past trends, drug pipelines, and leading companies. It serves investors, new entrants, and pharma firms looking ...
The pneumococcal conjugate vaccines that were studied were the PCV10 (GSK) and PCV13 (Pfizer). The saccharide in PCV10 is conjugated to nontypable Haemophilus influenzae protein D, tetanus toxoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results